Stockscreener 앱 받기
5.95
15.31%
0.79
시간 외 거래:
5.95
Agenus Inc 주식(AGEN)의 최신 뉴스
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million - Medical Dialogues
Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International
Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN
Agenus (NASDAQ:AGEN) Upgraded to “Buy” at HC Wainwright - Defense World
Agenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. Baird - Defense World
Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL - Medical Dialogues
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - 뉴스와이어
Agenus Announces Strategic Collaboration with Zydus - TipRanks
Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN
Agenus IncSigns Partnership Agreements With Zydus Lifesciences - marketscreener.com
Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangAgenus (NASDAQ:AGEN) - Benzinga
Agenus Shares Rise After Upgrade From HC Wainwright - marketscreener.com
H.C. Wainwright upgrades Agenus stock on strategic collaboration - Investing.com Australia
H.C. Wainwright upgrades Agenus stock on strategic collaboration By Investing.com - Investing.com South Africa
Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Yahoo Finance
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Mai - GuruFocus
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Maintained | AGEN Stock News - GuruFocus
HC Wainwright & Co. Upgrades Agenus (AGEN) - Nasdaq
Agenus (AGEN) Upgraded to 'Buy' by HC Wainwright & Co. | AGEN Stock News - GuruFocus
Agenus (AGEN) Stock Price Target Increased by Baird | AGEN Stock News - GuruFocus
Agenus and Zydus sign agreements for botensilimab and balstilimab - Yahoo Finance
Zydus gets rights for next gen I-O platforms from Agenus - The Pharma Letter
HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target - marketscreener.com
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | A - GuruFocus
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | AGEN Stock News - GuruFocus
Zydus, Agenus team up for next-gen cancer immunotherapies - Healthcare Radius
Jane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN) - Defense World
Zydus to acquire Agenus’ US manufacturing facilities, forays into global biologics CDMO business - Indian Pharma Post
Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - StreetInsider
Agenus inks $141M deal with Zydus for cancer drugs, facilities By Investing.com - Investing.com South Africa
Zydus acquires Agenus biologics facilities for CDMO expansion By Investing.com - Investing.com South Africa
Zydus Lifesciences to acquire Agenus’s two biologics units for USD 125M - Medical Buyer
With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business - financialexpress.com
Zydus Lifesciences Subsidiary Zynext to Acquire 5.9% Stake in Agenus for $16 Million - India Infoline
Zydus enters global biologics CDMO business, plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies - Equity Bulls
Zydus announces plan to acquire US manufacturing units of Agenus Inc - The Indian Express
Agenus Inc. announced that it expects to receive $15.75 million in funding from Zydus Lifesciences Limited - marketscreener.com
Zydus to acquire US biotech firm Agenus’ facilities in California - The Economic Times
Agenus Stock Is Trading Higher Tuesday: What's Going On? - Benzinga
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million - The Hindu
Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences - marketscreener.com
Zynext Ventures acquires stake in Agenus, expands its immuno-oncology pipeline and global reach - The Malaysian Reserve
Zydus buys Agenus' biologics plants in US for $125 mn, licenses cancer therapy | Company Business News - Mint
Zydus bolsters global biologics play with Agenus acquisition, immuno-oncology licensing pact - Fortune India
Zydus inks pact to acquire stake in US firm to enter contract manufacturing space - theweek.in
Zydus Lifesciences to Enter the Global CDMO Business - Contract Pharma
Zydus Life To Buy Agenus US Facilities For $75 Million For Entry In Biologics CDMO - NDTV Profit
Agenus (AGEN) Rises on Zydus Partnership to Boost Cancer Therapy - GuruFocus
Zydus forays into global bilogics CDMO business through acquisition of two facilities of Agenus Inc in the US - BusinessLine
Zydus acquires Agenus biologics facilities for CDMO expansion - Investing.com Australia
Zydus signs deal with Agenus for BOT and BAL cancer therapies in India - Business Standard
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies - Tribune India
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus' U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies - ANI News
Agenus (AGEN) Sells Biologics Facilities to Zydus Lifesciences | AGEN Stock News - GuruFocus
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus’ U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies - ThePrint
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies | AGEN Stock News - GuruFocus
Zydus Lifesciences to invest $16 million in US-based Agenus for 5.9% stake - CNBC TV18
Agenus and Zydus Lifesciences enter $141 M strategic collaboration for biologics manufacturing in US - BioSpectrum India
Zydus Lifesciences in licensing deal with America's Agenus for cancer therapy - Moneycontrol
Agenus (AGEN) Enters Strategic Partnership with Zydus Lifesciences | AGEN Stock News - GuruFocus
Agenus inks $141M deal with Zydus for cancer drugs, facilities - Investing.com Nigeria
Agenus stock climbs Zydus deal for BOT/BAL (AGEN:NASDAQ) - Seeking Alpha
Agenus shares leap on strategic collaboration with Zydus Lifesciences By Investing.com - Investing.com South Africa
0.00%
2.33%
자본화:
|
볼륨(24시간):